Live Breaking News & Updates on Impaired Hepatic

Stay updated with breaking news from Impaired hepatic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Clinical Data on GENFIT's Investigational Compound

Lille, France; Cambridge, MA; November 02, 2021 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the. ....

United States , United Kingdom , France General , Benoit Noel , Stephanie Boyer , Exchange Commission , Uncertainties Of The Company , American Association , Liver Diseases , Liver Meeting , Impaired Hepatic , Human Cholestatic , Autoimmune Liver Diseases , Liver Meeting Digital Experience , Chronic Liver Failure , Primary Biliary Cholangitis , Primary Sclerosing Cholangitis , Nasdaq Global Select Market , Breakthrough Therapy , Private Securities Litigation Reform Act , French Autorit , Des March , Registration Document , Paris Stock Exchange Gnft , Genfit Sa ,